While CRM treatment alone ameliorated the altered activities of SOD and CAT in both the altered thyroid conditions, VIT-E alone could stabilize SOD and CAT in hyper-thyroid model only and failed to elicit any response in the hypo-thyroid model. This evidence concerns the gene SOD1 and thyroid gland disorder.